+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Eprazinone Market by Dosage Form (Injection, Syrup, Tablets), Route Of Administration (Oral, Parenteral), Distribution Channel, End User, Indication - Global Forecast 2025-2030- Product Image
Eprazinone Market by Dosage Form (Injection, Syrup, Tablets), Route Of Administration (Oral, Parenteral), Distribution Channel, End User, Indication - Global Forecast 2025-2030- Product Image
Sale

Eprazinone Market by Dosage Form (Injection, Syrup, Tablets), Route Of Administration (Oral, Parenteral), Distribution Channel, End User, Indication - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 195 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5967828
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Eprazinone’s market trajectory signals robust, sustained growth driven by dynamic regulatory changes, advancing clinical findings, and innovation in patient-centric care solutions for respiratory conditions.

Market Snapshot: Eprazinone Market Size and Growth

The Eprazinone market grew from USD 18.60 billion in 2024 to USD 20.13 billion in 2025. It is projected to continue expanding at a CAGR of 8.16%, reaching USD 29.78 billion by 2030. This outlook is shaped by regulatory shifts and technological advances augmenting both use and market access across diverse regions and healthcare systems.

Scope & Segmentation

This report delivers a strategic overview and in-depth assessment of the Eprazinone market, offering actionable segmentation for informed decision-making across the value chain.

  • Dosage Forms: Injection, Syrup, Tablets (including Immediate Release and Sustained Release)
  • Routes of Administration: Oral, Parenteral
  • Distribution Channels: Hospital Pharmacies, Online Pharmacies, Retail Pharmacies (Chain and Independent)
  • End Users: Clinics, Home Care, Hospitals
  • Indications: Acute Bronchitis, Asthma, Chronic Bronchitis
  • Regions Analyzed: Americas (including United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including United Kingdom, Germany, France, and others), Asia-Pacific (China, India, Japan, among others)
  • Leading Companies: Teva Pharmaceutical Industries Ltd., Sandoz International GmbH, Viatris Inc., Sun Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Ltd., Lupin Limited, Cipla Limited, Glenmark Pharmaceuticals Limited, Zydus Lifesciences Limited, Intas Pharmaceuticals Limited

Key Takeaways: Eprazinone Market Insights

  • Sustained release advances and diversified injectable options support improved adherence and therapeutic flexibility for healthcare providers and patients.
  • Value-based care models are prompting the integration of real-world evidence and patient-reported outcomes into commercial and regulatory strategies.
  • Digital health technologies, such as remote monitoring and adherence tracking platforms, are beginning to influence treatment optimization and patient engagement.
  • Manufacturers are leveraging strategic alliances with contract manufacturing and research organizations to localize production and streamline regional market access.
  • Adaptive distribution strategies address distinct needs across hospital, retail, and online pharmacy segments, ensuring availability and responsiveness to patient preference shifts.

Tariff Impact: Navigating U.S. Policy Changes

Forthcoming United States tariff measures in 2025 add complexity to procurement and supply chain planning for Eprazinone. Companies are actively diversifying supplier networks and assessing regional manufacturing solutions to minimize trade disruption risks. Adjustments to pricing models and transparent stakeholder communication will be necessary to support continued market access in the face of rising input costs and shifting logistics.

Methodology & Data Sources

This study draws on structured interviews with pharmaceutical executives, clinical investigators, and market access specialists, complemented by secondary research from peer-reviewed journals, regulatory updates, and clinical trial data. Analytical frameworks include triangulation and sensitivity analysis, with expert validation ensuring reliability and depth.

Why This Report Matters

  • Equips senior decision-makers with timely insights to drive regulatory alignment, lifecycle management, and focused commercialization strategies.
  • Provides segmentation and regional breakdowns to enable targeted investments in product development and distribution.
  • Highlights evolving market trends, including digital health adoption and tariff challenges, to support proactive risk mitigation and supply chain continuity.

Conclusion

The Eprazinone market stands at the intersection of regulatory transformation, clinical progress, and patient-focused care. Informed strategic planning, technology adoption, and supply chain agility will be key to sustaining commercial success in this evolving therapeutic area.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Rising demand for eprazinone generics driven by expiration of key patents and pricing pressures
5.2. Growth in novel inhalation delivery formats for eprazinone to improve patient adherence and bioavailability
5.3. Impact of stringent environmental emission regulations on eprazinone API manufacturing processes
5.4. Expansion of over-the-counter eprazinone formulations in emerging markets boosting accessibility and revenue
5.5. Strategic partnerships between contract development organizations and eprazinone manufacturers to accelerate formulation development
5.6. Influence of digital health integrations for monitoring chronic bronchitis symptoms treated with eprazinone
5.7. Implementation of continuous flow chemistry for sustainable large scale eprazinone production and cost reduction
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Eprazinone Market, by Dosage Form
8.1. Introduction
8.2. Injection
8.3. Syrup
8.4. Tablets
8.4.1. Immediate Release
8.4.2. Sustained Release
9. Eprazinone Market, by Route Of Administration
9.1. Introduction
9.2. Oral
9.3. Parenteral
10. Eprazinone Market, by Distribution Channel
10.1. Introduction
10.2. Hospital Pharmacies
10.3. Online Pharmacies
10.4. Retail Pharmacies
10.4.1. Chain
10.4.2. Independent
11. Eprazinone Market, by End User
11.1. Introduction
11.2. Clinics
11.3. Home Care
11.4. Hospitals
12. Eprazinone Market, by Indication
12.1. Introduction
12.2. Acute Bronchitis
12.3. Asthma
12.4. Chronic Bronchitis
13. Americas Eprazinone Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Eprazinone Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Eprazinone Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Teva Pharmaceutical Industries Ltd.
16.3.2. Sandoz International GmbH
16.3.3. Viatris Inc.
16.3.4. Sun Pharmaceutical Industries Ltd.
16.3.5. Dr. Reddy’s Laboratories Ltd.
16.3.6. Lupin Limited
16.3.7. Cipla Limited
16.3.8. Glenmark Pharmaceuticals Limited
16.3.9. Zydus Lifesciences Limited
16.3.10. Intas Pharmaceuticals Limited
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. EPRAZINONE MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL EPRAZINONE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL EPRAZINONE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL EPRAZINONE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL EPRAZINONE MARKET SIZE, BY DOSAGE FORM, 2024 VS 2030 (%)
FIGURE 6. GLOBAL EPRAZINONE MARKET SIZE, BY DOSAGE FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL EPRAZINONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL EPRAZINONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 10. GLOBAL EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL EPRAZINONE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL EPRAZINONE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL EPRAZINONE MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL EPRAZINONE MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS EPRAZINONE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS EPRAZINONE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES EPRAZINONE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES EPRAZINONE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA EPRAZINONE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA EPRAZINONE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC EPRAZINONE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC EPRAZINONE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EPRAZINONE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. EPRAZINONE MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. EPRAZINONE MARKET: RESEARCHAI
FIGURE 26. EPRAZINONE MARKET: RESEARCHSTATISTICS
FIGURE 27. EPRAZINONE MARKET: RESEARCHCONTACTS
FIGURE 28. EPRAZINONE MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. EPRAZINONE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL EPRAZINONE MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL EPRAZINONE MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL EPRAZINONE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL EPRAZINONE MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL EPRAZINONE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL EPRAZINONE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL EPRAZINONE MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL EPRAZINONE MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL EPRAZINONE MARKET SIZE, BY INJECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL EPRAZINONE MARKET SIZE, BY INJECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL EPRAZINONE MARKET SIZE, BY SYRUP, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL EPRAZINONE MARKET SIZE, BY SYRUP, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL EPRAZINONE MARKET SIZE, BY TABLETS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL EPRAZINONE MARKET SIZE, BY TABLETS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL EPRAZINONE MARKET SIZE, BY IMMEDIATE RELEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL EPRAZINONE MARKET SIZE, BY IMMEDIATE RELEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL EPRAZINONE MARKET SIZE, BY SUSTAINED RELEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL EPRAZINONE MARKET SIZE, BY SUSTAINED RELEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL EPRAZINONE MARKET SIZE, BY TABLETS, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL EPRAZINONE MARKET SIZE, BY TABLETS, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL EPRAZINONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL EPRAZINONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL EPRAZINONE MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL EPRAZINONE MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL EPRAZINONE MARKET SIZE, BY PARENTERAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL EPRAZINONE MARKET SIZE, BY PARENTERAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL EPRAZINONE MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL EPRAZINONE MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL EPRAZINONE MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL EPRAZINONE MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL EPRAZINONE MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL EPRAZINONE MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL EPRAZINONE MARKET SIZE, BY CHAIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL EPRAZINONE MARKET SIZE, BY CHAIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL EPRAZINONE MARKET SIZE, BY INDEPENDENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL EPRAZINONE MARKET SIZE, BY INDEPENDENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL EPRAZINONE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL EPRAZINONE MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL EPRAZINONE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL EPRAZINONE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL EPRAZINONE MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL EPRAZINONE MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL EPRAZINONE MARKET SIZE, BY HOME CARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL EPRAZINONE MARKET SIZE, BY HOME CARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL EPRAZINONE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL EPRAZINONE MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL EPRAZINONE MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL EPRAZINONE MARKET SIZE, BY ACUTE BRONCHITIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL EPRAZINONE MARKET SIZE, BY ACUTE BRONCHITIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL EPRAZINONE MARKET SIZE, BY ASTHMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL EPRAZINONE MARKET SIZE, BY ASTHMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL EPRAZINONE MARKET SIZE, BY CHRONIC BRONCHITIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL EPRAZINONE MARKET SIZE, BY CHRONIC BRONCHITIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. AMERICAS EPRAZINONE MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 60. AMERICAS EPRAZINONE MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 61. AMERICAS EPRAZINONE MARKET SIZE, BY TABLETS, 2018-2024 (USD MILLION)
TABLE 62. AMERICAS EPRAZINONE MARKET SIZE, BY TABLETS, 2025-2030 (USD MILLION)
TABLE 63. AMERICAS EPRAZINONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 64. AMERICAS EPRAZINONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 65. AMERICAS EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 66. AMERICAS EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 67. AMERICAS EPRAZINONE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 68. AMERICAS EPRAZINONE MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS EPRAZINONE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS EPRAZINONE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS EPRAZINONE MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS EPRAZINONE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS EPRAZINONE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 75. UNITED STATES EPRAZINONE MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 76. UNITED STATES EPRAZINONE MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 77. UNITED STATES EPRAZINONE MARKET SIZE, BY TABLETS, 2018-2024 (USD MILLION)
TABLE 78. UNITED STATES EPRAZINONE MARKET SIZE, BY TABLETS, 2025-2030 (USD MILLION)
TABLE 79. UNITED STATES EPRAZINONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 80. UNITED STATES EPRAZINONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 81. UNITED STATES EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 82. UNITED STATES EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 83. UNITED STATES EPRAZINONE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 84. UNITED STATES EPRAZINONE MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 85. UNITED STATES EPRAZINONE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 86. UNITED STATES EPRAZINONE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 87. UNITED STATES EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 88. UNITED STATES EPRAZINONE MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 89. UNITED STATES EPRAZINONE MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 90. UNITED STATES EPRAZINONE MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 91. CANADA EPRAZINONE MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 92. CANADA EPRAZINONE MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 93. CANADA EPRAZINONE MARKET SIZE, BY TABLETS, 2018-2024 (USD MILLION)
TABLE 94. CANADA EPRAZINONE MARKET SIZE, BY TABLETS, 2025-2030 (USD MILLION)
TABLE 95. CANADA EPRAZINONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 96. CANADA EPRAZINONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 97. CANADA EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 98. CANADA EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 99. CANADA EPRAZINONE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 100. CANADA EPRAZINONE MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 101. CANADA EPRAZINONE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 102. CANADA EPRAZINONE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 103. CANADA EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 104. CANADA EPRAZINONE MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 105. MEXICO EPRAZINONE MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 106. MEXICO EPRAZINONE MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 107. MEXICO EPRAZINONE MARKET SIZE, BY TABLETS, 2018-2024 (USD MILLION)
TABLE 108. MEXICO EPRAZINONE MARKET SIZE, BY TABLETS, 2025-2030 (USD MILLION)
TABLE 109. MEXICO EPRAZINONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 110. MEXICO EPRAZINONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 111. MEXICO EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 112. MEXICO EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 113. MEXICO EPRAZINONE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 114. MEXICO EPRAZINONE MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 115. MEXICO EPRAZINONE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 116. MEXICO EPRAZINONE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 117. MEXICO EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 118. MEXICO EPRAZINONE MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 119. BRAZIL EPRAZINONE MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 120. BRAZIL EPRAZINONE MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 121. BRAZIL EPRAZINONE MARKET SIZE, BY TABLETS, 2018-2024 (USD MILLION)
TABLE 122. BRAZIL EPRAZINONE MARKET SIZE, BY TABLETS, 2025-2030 (USD MILLION)
TABLE 123. BRAZIL EPRAZINONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 124. BRAZIL EPRAZINONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 125. BRAZIL EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 126. BRAZIL EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 127. BRAZIL EPRAZINONE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 128. BRAZIL EPRAZINONE MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 129. BRAZIL EPRAZINONE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 130. BRAZIL EPRAZINONE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 131. BRAZIL EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 132. BRAZIL EPRAZINONE MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 133. ARGENTINA EPRAZINONE MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 134. ARGENTINA EPRAZINONE MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 135. ARGENTINA EPRAZINONE MARKET SIZE, BY TABLETS, 2018-2024 (USD MILLION)
TABLE 136. ARGENTINA EPRAZINONE MARKET SIZE, BY TABLETS, 2025-2030 (USD MILLION)
TABLE 137. ARGENTINA EPRAZINONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 138. ARGENTINA EPRAZINONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 139. ARGENTINA EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 140. ARGENTINA EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 141. ARGENTINA EPRAZINONE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 142. ARGENTINA EPRAZINONE MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 143. ARGENTINA EPRAZINONE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 144. ARGENTINA EPRAZINONE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 145. ARGENTINA EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 146. ARGENTINA EPRAZINONE MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 147. EUROPE, MIDDLE EAST & AFRICA EPRAZINONE MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 148. EUROPE, MIDDLE EAST & AFRICA EPRAZINONE MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 149. EUROPE, MIDDLE EAST & AFRICA EPRAZINONE MARKET SIZE, BY TABLETS, 2018-2024 (USD MILLION)
TABLE 150. EUROPE, MIDDLE EAST & AFRICA EPRAZINONE MARKET SIZE, BY TABLETS, 2025-2030 (USD MILLION)
TABLE 151. EUROPE, MIDDLE EAST & AFRICA EPRAZINONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 152. EUROPE, MIDDLE EAST & AFRICA EPRAZINONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA EPRAZINONE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA EPRAZINONE MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA EPRAZINONE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA EPRAZINONE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA EPRAZINONE MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA EPRAZINONE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA EPRAZINONE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 163. UNITED KINGDOM EPRAZINONE MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 164. UNITED KINGDOM EPRAZINONE MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 165. UNITED KINGDOM EPRAZINONE MARKET SIZE, BY TABLETS, 2018-2024 (USD MILLION)
TABLE 166. UNITED KINGDOM EPRAZINONE MARKET SIZE, BY TABLETS, 2025-2030 (USD MILLION)
TABLE 167. UNITED KINGDOM EPRAZINONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 168. UNITED KINGDOM EPRAZINONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 169. UNITED KINGDOM EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 170. UNITED KINGDOM EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 171. UNITED KINGDOM EPRAZINONE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 172. UNITED KINGDOM EPRAZINONE MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 173. UNITED KINGDOM EPRAZINONE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 174. UNITED KINGDOM EPRAZINONE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 175. UNITED KINGDOM EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 176. UNITED KINGDOM EPRAZINONE MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 177. GERMANY EPRAZINONE MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 178. GERMANY EPRAZINONE MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 179. GERMANY EPRAZINONE MARKET SIZE, BY TABLETS, 2018-2024 (USD MILLION)
TABLE 180. GERMANY EPRAZINONE MARKET SIZE, BY TABLETS, 2025-2030 (USD MILLION)
TABLE 181. GERMANY EPRAZINONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 182. GERMANY EPRAZINONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 183. GERMANY EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 184. GERMANY EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 185. GERMANY EPRAZINONE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 186. GERMANY EPRAZINONE MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 187. GERMANY EPRAZINONE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 188. GERMANY EPRAZINONE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 189. GERMANY EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 190. GERMANY EPRAZINONE MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 191. FRANCE EPRAZINONE MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 192. FRANCE EPRAZINONE MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 193. FRANCE EPRAZINONE MARKET SIZE, BY TABLETS, 2018-2024 (USD MILLION)
TABLE 194. FRANCE EPRAZINONE MARKET SIZE, BY TABLETS, 2025-2030 (USD MILLION)
TABLE 195. FRANCE EPRAZINONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 196. FRANCE EPRAZINONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 197. FRANCE EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 198. FRANCE EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 199. FRANCE EPRAZINONE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 200. FRANCE EPRAZINONE MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 201. FRANCE EPRAZINONE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 202. FRANCE EPRAZINONE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 203. FRANCE EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 204. FRANCE EPRAZINONE MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 205. RUSSIA EPRAZINONE MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 206. RUSSIA EPRAZINONE MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 207. RUSSIA EPRAZINONE MARKET SIZE, BY TABLETS, 2018-2024 (USD MILLION)
TABLE 208. RUSSIA EPRAZINONE MARKET SIZE, BY TABLETS, 2025-2030 (USD MILLION)
TABLE 209. RUSSIA EPRAZINONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 210. RUSSIA EPRAZINONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 211. RUSSIA EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 212. RUSSIA EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 213. RUSSIA EPRAZINONE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 214. RUSSIA EPRAZINONE MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 215. RUSSIA EPRAZINONE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 216. RUSSIA EPRAZINONE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 217. RUSSIA EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 218. RUSSIA EPRAZINONE MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 219. ITALY EPRAZINONE MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 220. ITALY EPRAZINONE MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 221. ITALY EPRAZINONE MARKET SIZE, BY TABLETS, 2018-2024 (USD MILLION)
TABLE 222. ITALY EPRAZINONE MARKET SIZE, BY TABLETS, 2025-2030 (USD MILLION)
TABLE 223. ITALY EPRAZINONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 224. ITALY EPRAZINONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 225. ITALY EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 226. ITALY EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 227. ITALY EPRAZINONE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 228. ITALY EPRAZINONE MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 229. ITALY EPRAZINONE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 230. ITALY EPRAZINONE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 231. ITALY EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 232. ITALY EPRAZINONE MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 233. SPAIN EPRAZINONE MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 234. SPAIN EPRAZINONE MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 235. SPAIN EPRAZINONE MARKET SIZE, BY TABLETS, 2018-2024 (USD MILLION)
TABLE 236. SPAIN EPRAZINONE MARKET SIZE, BY TABLETS, 2025-2030 (USD MILLION)
TABLE 237. SPAIN EPRAZINONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 238. SPAIN EPRAZINONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 239. SPAIN EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 240. SPAIN EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 241. SPAIN EPRAZINONE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 242. SPAIN EPRAZINONE MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 243. SPAIN EPRAZINONE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 244. SPAIN EPRAZINONE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 245. SPAIN EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 246. SPAIN EPRAZINONE MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 247. UNITED ARAB EMIRATES EPRAZINONE MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 248. UNITED ARAB EMIRATES EPRAZINONE MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 249. UNITED ARAB EMIRATES EPRAZINONE MARKET SIZE, BY TABLETS, 2018-2024 (USD MILLION)
TABLE 250. UNITED ARAB EMIRATES EPRAZINONE MARKET SIZE, BY TABLETS, 2025-2030 (USD MILLION)
TABLE 251. UNITED ARAB EMIRATES EPRAZINONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 252. UNITED ARAB EMIRATES EPRAZINONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 253. UNITED ARAB EMIRATES EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 254. UNITED ARAB EMIRATES EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 255. UNITED ARAB EMIRATES EPRAZINONE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 256. UNITED ARAB EMIRATES EPRAZINONE MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 257. UNITED ARAB EMIRATES EPRAZINONE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 258. UNITED ARAB EMIRATES EPRAZINONE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 259. UNITED ARAB EMIRATES EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 260. UNITED ARAB EMIRATES EPRAZINONE MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 261. SAUDI ARABIA EPRAZINONE MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 262. SAUDI ARABIA EPRAZINONE MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 263. SAUDI ARABIA EPRAZINONE MARKET SIZE, BY TABLETS, 2018-2024 (USD MILLION)
TABLE 264. SAUDI ARABIA EPRAZINONE MARKET SIZE, BY TABLETS, 2025-2030 (USD MILLION)
TABLE 265. SAUDI ARABIA EPRAZINONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 266. SAUDI ARABIA EPRAZINONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 267. SAUDI ARABIA EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 268. SAUDI ARABIA EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 269. SAUDI ARABIA EPRAZINONE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 270. SAUDI ARABIA EPRAZINONE MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 271. SAUDI ARABIA EPRAZINONE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 272. SAUDI ARABIA EPRAZINONE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 273. SAUDI ARABIA EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 274. SAUDI ARABIA EPRAZINONE MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 275. SOUTH AFRICA EPRAZINONE MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 276. SOUTH AFRICA EPRAZINONE MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 277. SOUTH AFRICA EPRAZINONE MARKET SIZE, BY TABLETS, 2018-2024 (USD MILLION)
TABLE 278. SOUTH AFRICA EPRAZINONE MARKET SIZE, BY TABLETS, 2025-2030 (USD MILLION)
TABLE 279. SOUTH AFRICA EPRAZINONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 280. SOUTH AFRICA EPRAZINONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 281. SOUTH AFRICA EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 282. SOUTH AFRICA EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 283. SOUTH AFRICA EPRAZINONE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 284. SOUTH AFRICA EPRAZINONE MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 285. SOUTH AFRICA EPRAZINONE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 286. SOUTH AFRICA EPRAZINONE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 287. SOUTH AFRICA EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 288. SOUTH AFRICA EPRAZINONE MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 289. DENMARK EPRAZINONE MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 290. DENMARK EPRAZINONE MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 291. DENMARK EPRAZINONE MARKET SIZE, BY TABLETS, 2018-2024 (USD MILLION)
TABLE 292. DENMARK EPRAZINONE MARKET SIZE, BY TABLETS, 2025-2030 (USD MILLION)
TABLE 293. DENMARK EPRAZINONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 294. DENMARK EPRAZINONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 295. DENMARK EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 296. DENMARK EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 297. DENMARK EPRAZINONE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 298. DENMARK EPRAZINONE MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 299. DENMARK EPRAZINONE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 300. DENMARK EPRAZINONE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 301. DENMARK EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 302. DENMARK EPRAZINONE MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 303. NETHERLANDS EPRAZINONE MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 304. NETHERLANDS EPRAZINONE MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 305. NETHERLANDS EPRAZINONE MARKET SIZE, BY TABLETS, 2018-2024 (USD MILLION)
TABLE 306. NETHERLANDS EPRAZINONE MARKET SIZE, BY TABLETS, 2025-2030 (USD MILLION)
TABLE 307. NETHERLANDS EPRAZINONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 308. NETHERLANDS EPRAZINONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 309. NETHERLANDS EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 310. NETHERLANDS EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 311. NETHERLANDS EPRAZINONE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 312. NETHERLANDS EPRAZINONE MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 313. NETHERLANDS EPRAZINONE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 314. NETHERLANDS EPRAZINONE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 315. NETHERLANDS EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 316. NETHERLANDS EPRAZINONE MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 317. QATAR EPRAZINONE MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 318. QATAR EPRAZINONE MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 319. QATAR EPRAZINONE MARKET SIZE, BY TABLETS, 2018-2024 (USD MILLION)
TABLE 320. QATAR EPRAZINONE MARKET SIZE, BY TABLETS, 2025-2030 (USD MILLION)
TABLE 321. QATAR EPRAZINONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 322. QATAR EPRAZINONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 323. QATAR EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 324. QATAR EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 325. QATAR EPRAZINONE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 326. QATAR EPRAZINONE MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 327. QATAR EPRAZINONE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 328. QATAR EPRAZINONE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 329. QATAR EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 330. QATAR EPRAZINONE MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 331. FINLAND EPRAZINONE MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 332. FINLAND EPRAZINONE MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 333. FINLAND EPRAZINONE MARKET SIZE, BY TABLETS, 2018-2024 (USD MILLION)
TABLE 334. FINLAND EPRAZINONE MARKET SIZE, BY TABLETS, 2025-2030 (USD MILLION)
TABLE 335. FINLAND EPRAZINONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 336. FINLAND EPRAZINONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 337. FINLAND EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 338. FINLAND EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 339. FINLAND EPRAZINONE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 340. FINLAND EPRAZINONE MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 341. FINLAND EPRAZINONE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 342. FINLAND EPRAZINONE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 343. FINLAND EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 344. FINLAND EPRAZINONE MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 345. SWEDEN EPRAZINONE MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 346. SWEDEN EPRAZINONE MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 347. SWEDEN EPRAZINONE MARKET SIZE, BY TABLETS, 2018-2024 (USD MILLION)
TABLE 348. SWEDEN EPRAZINONE MARKET SIZE, BY TABLETS, 2025-2030 (USD MILLION)
TABLE 349. SWEDEN EPRAZINONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 350. SWEDEN EPRAZINONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 351. SWEDEN EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 352. SWEDEN EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 353. SWEDEN EPRAZINONE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 354. SWEDEN EPRAZINONE MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 355. SWEDEN EPRAZINONE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 356. SWEDEN EPRAZINONE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 357. SWEDEN EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 358. SWEDEN EPRAZINONE MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 359. NIGERIA EPRAZINONE MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 360. NIGERIA EPRAZINONE MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 361. NIGERIA EPRAZINONE MARKET SIZE, BY TABLETS, 2018-2024 (USD MILLION)
TABLE 362. NIGERIA EPRAZINONE MARKET SIZE, BY TABLETS, 2025-2030 (USD MILLION)
TABLE 363. NIGERIA EPRAZINONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 364. NIGERIA EPRAZINONE MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 365. NIGERIA EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 366. NIGERIA EPRAZINONE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 367. NIGERIA EPRAZINONE MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 368. NIGERIA EPRAZINONE MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 369. NIGERIA EPRAZINONE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 370. NIGERIA EPRAZINONE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 371. NIGERIA EPRAZINONE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 372. NIGERIA EPRAZINONE MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 373. EGYPT EPRAZINONE MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 374. EGYPT EPRAZINONE MARKET SIZE, B

Samples

Loading
LOADING...

Companies Mentioned

The major companies profiled in this Eprazinone market report include:
  • Teva Pharmaceutical Industries Ltd.
  • Sandoz International GmbH
  • Viatris Inc.
  • Sun Pharmaceutical Industries Ltd.
  • Dr. Reddy’s Laboratories Ltd.
  • Lupin Limited
  • Cipla Limited
  • Glenmark Pharmaceuticals Limited
  • Zydus Lifesciences Limited
  • Intas Pharmaceuticals Limited

Table Information

Report AttributeDetails
No. of Pages195
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 20.13 Billion
Forecasted Market Value ( USD ) by 2030 $ 29.78 Billion
Compound Annual Growth Rate8.1%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Eprazinone (CAS 10402-90-1) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - Product Image

Eprazinone (CAS 10402-90-1) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

  • Report
  • 50 Pages
  • Global
From
Rivaroxaban Drugs Market by Route of Administration (Oral), Dosage Form (Film Coated Tablet), Distribution Channel, Indication, Strength - Global Forecast 2025-2030 - Product Image

Rivaroxaban Drugs Market by Route of Administration (Oral), Dosage Form (Film Coated Tablet), Distribution Channel, Indication, Strength - Global Forecast 2025-2030

  • Report
  • 184 Pages
  • Global
From
Azithromycin Market by Product Type (Branded, Generic), Dosage Form (Capsule, Suspension, Tablet), Route of Administration, Indication, End User, Sales Channel - Global Forecast 2025-2030 - Product Image

Azithromycin Market by Product Type (Branded, Generic), Dosage Form (Capsule, Suspension, Tablet), Route of Administration, Indication, End User, Sales Channel - Global Forecast 2025-2030

  • Report
  • 182 Pages
  • Global
From
Tuberculosis Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Tuberculosis Therapeutics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 180 Pages
  • Global
From
Cystic Fibrosis Therapeutics Market Size, Share & Trends Analysis Report by Drug Class (Pancreatic Enzyme Supplements), Route of Administration (Oral), Distribution Channel, Region, and Segment Forecasts, 2025-2030 - Product Image

Cystic Fibrosis Therapeutics Market Size, Share & Trends Analysis Report by Drug Class (Pancreatic Enzyme Supplements), Route of Administration (Oral), Distribution Channel, Region, and Segment Forecasts, 2025-2030

  • Report
  • 90 Pages
  • Global
From

About the Eprazinone Market

Eprazinone is a respiratory drug used to treat asthma and chronic obstructive pulmonary disease (COPD). It is a long-acting beta-agonist (LABA) that works by relaxing the muscles of the airways, allowing more air to flow in and out of the lungs. It is often used in combination with an inhaled corticosteroid (ICS) to provide better control of symptoms. Eprazinone is available in both brand-name and generic forms. Eprazinone is a relatively new drug, having been approved by the US Food and Drug Administration (FDA) in 2019. It is currently available in the US, Canada, and Europe. It is also being studied for use in other countries. Eprazinone is marketed by several pharmaceutical companies, including GlaxoSmithKline, Merck, and Novartis. Other companies involved in the market include Mylan, Teva, and Sun Pharmaceuticals. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.